microbiome-based therapy
Microbiota-Based Therapy for the Prevention of Recurrent Clostridioides difficile Infection:
A Primer on REBYOTA®
(fecal microbiota, live-jslm)
This Special Report outlines the challenges of treating Clostridioides difficile infection (CDI) and preventing ...
AUGUST 29, 2023
Microbiome Enrichment Bests Placebo for Recurrent C. difficile
Phase 3 study results show that a microbiome therapeutic consisting of purified Firmicutes spores reduced the risk ...
AUGUST 24, 2021
Microbiome-Based Therapy: The Next Frontier in the Management of Clostridioides difficile Infections and Recurrence
This Special Report describes the gut microbiome, the burden of Clostridioides difficile infection (CDI) and ...
JANUARY 12, 2021
Load more